IMR
IMRICOR CDI FORUS [IMR]
Healthcare · ASX Small Cap
$1.8850 -0.5%
Updated 9 Sep 2026 · Signals refresh every scan
Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when IMR triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- MACD momentum is losing steam
- Volume surging at 2.8x normal while price falls — heavy selling pressure
- Sitting near support — this level has held before and could attract buyers again
- Trading above the 200-day average — the long-term trend is on your side
- Strong cash runway (11 quarters)
- Very high P/S ratio (5747.9x)
- EPS estimates revised upward (+10pts)
- CANSLIM I: Institutional ownership (16%)
- Sentiment is mixed — no strong consensus either way
- Positive long-term momentum — up 41% over the past year
- The bigger volume days are the up days — volume-weighted momentum is positive (0.63%/day)
- RBA hiking (-3pts)
Risk Signals
- Revenue declining (-7%)
- Piotroski F-Score weak (3/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
Expected next for IMR
18 Oct 2026Regulatory ApprovalEstimated from past filings
Window: 11 Oct to 25 Oct
The last 3 moved IMR 0.0% on the day, on average — an observation, not a guide to what happens next.
Window: 5 Nov to 19 Nov
The last 6 moved IMR 0.0% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →
Recent Catalysts
NONE S&P DJI Announces September 2026 Quarterly Rebalance
NONE FDA Accepts Imricor PMA Manufacturing Module
NONE Release from Voluntary Escrow
Announcement tone +3pts
Recent ASX Announcements
| 2026-09-04 | S&P DJI Announces September 2026 Quarterly Rebalance PRICE SENSITIVE |
| 2026-09-02 | FDA Accepts Imricor PMA Manufacturing Module PRICE SENSITIVE |
| 2026-08-28 | Release from Voluntary Escrow |
| 2026-08-27 | Imricor and Philips Launch Commercial iMR Lab Solution PRICE SENSITIVE |
| 2026-08-09 | Imricor U.S. Commercial Momentum Accelerates PRICE SENSITIVE |
Key Metrics
$690.2M
Market Cap
478K
Avg Volume
2.8x
Vol Ratio
$1.27 — $2.25
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
-143.1%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 86% |
| L | Leader vs Laggard | laggard | RS: 0 |
| I | Institutional Sponsorship | pass | Inst: 16% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
110 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track IMR and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required